Rolapitant Hydrochloridis Hydrate Intermedii CAS 1214741-21-5 Puritas >98.5% (HPLC) ee >99.0%
Shanghai Ruifu Chemical Co., Ltd. est opificem rolapitantis hydrochloridi hydrochloridi intermedii (CAS: 1214741-21-5) cum qualitate magna.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Rolapitant Hydrochloridis Hydrate Intermedia,Please contact: alvin@ruifuchem.com
Nomen chemicum | (3R,7aR)-3-(tert-Butyl)-1-Hydroxy-7a-Vinyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one |
Synonyma | Rolapitant medium 1;(3R,7aR)-3-(1,1-Dimethylethyl)-7a-Ethenyltetrahydro-1-hydroxy-3H,5H-Pyrrolo[1,2-c]oxazol-5-one;3-(1,1-Dimethylethyl) -7a-Ethenyltetrahydro-1-Hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-unus |
Stock Status | In Stock, Commercial Productio |
CAS Number | 1214741-21-5 |
Formulae hypotheticae | C12H19NO3 |
M. Pondus | 225.28 g/mol |
Density | 1.16±0.10 g/cm3 |
COA & MSDS | Praesto |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Specifications | Proventus |
Aspectus | Solidus albus | Solidus albus |
Aquae Caroli Fischer | <0.50% | 0.15% |
Residere in Ignition | <0.50% | <0.10% |
Puritas / Analysis Methodus | >98.5% (HPLC) | 99.3% |
e Puritas | >99.0% (Chiral HPLC) | 99.86% |
400MHz 1H-NMR Imaginum | Congruunt Structure | Obsequitur |
LCMS | Congruunt Structure | Obsequitur |
conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
Applicationem | Intermedia Hydrochloridis Hydratis Rolapitantis (CAS: 914462-92-3) |
Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A nuditate lucis et humidi protege, ne ignem.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
(3R,7aR)-3-(tert-Butyl)-1-Hydroxy-7a-Vinyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-unum (CAS: 1214741-21-5) medium est inter Rolapitant. Hydrochloride Hydrate (CAS: 914462-92-3).Hydrochloridis hydrochloridis rolapitantis adhibetur ad nauseam retardatam et vomitum praecavendum cum initialibus et iteratis cursibus chemotherapy emetogenici cancri.Hydrochloridi hydrochloridi rolapitant, a Schering-Pough primum inventa et postea a TESARO, Inc. evoluta, probata est a FDA mense Septembri 2015 ob nauseam et vomitum (CINV) cum aliis agentibus antiemeticis retardati chemotherapy-inducti ne.